{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T22:18:45Z","timestamp":1777501125380,"version":"3.51.4"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,28]]},"DOI":"10.7759\/cureus.107884","type":"journal-article","created":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T15:15:59Z","timestamp":1777389359000},"source":"Crossref","is-referenced-by-count":0,"title":["Successful Therapeutic Approach to Facial Hyperpigmentation Secondary to Addison\u2019s Disease: A Case Report and Literature Review"],"prefix":"10.7759","author":[{"given":"Laura  A","family":"Colorado Franco","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melanie","family":"Villamizar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cindy Lorena","family":"Caceres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9sar","family":"Gonz\u00e1lez Ardila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angie Julieth","family":"Holgu\u00edn Molina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-1710","article-title":"Diagnosis and treatment of primary adrenal insufficiency: an Endocrine Society clinical practice guideline","volume":"101","author":"Bornstein SR","year":"2016","unstructured":"Bornstein SR, Allolio B, Arlt W, et al.. Diagnosis and treatment of primary adrenal insufficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2016, 101:364-89. 10.1210\/jc.2015-1710","journal-title":"J Clin Endocrinol Metab"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00136-7","article-title":"Adrenal insufficiency","volume":"397","author":"Husebye ES","year":"2021","unstructured":"Husebye ES, Pearce SH, Krone NP, K\u00e4mpe O. Adrenal insufficiency. Lancet. 2021, 397:613-29. 10.1016\/S0140-6736(21)00136-7","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2006.04.006","article-title":"Addison's disease","volume":"24","author":"Nieman LK","year":"2006","unstructured":"Nieman LK, Chanco Turner ML. Addison's disease. Clin Dermatol. 2006, 24:276-80. 10.1016\/j.clindermatol.2006.04.006","journal-title":"Clin Dermatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2009.10.051","article-title":"Reliability assessment and validation of the Melasma Area and Severity Index (MASI) and a new modified MASI scoring method","volume":"64","author":"Pandya AG","year":"2011","unstructured":"Pandya AG, Hynan LS, Bhore R, et al.. Reliability assessment and validation of the Melasma Area and Severity Index (MASI) and a new modified MASI scoring method. J Am Acad Dermatol. 2011, 64:78-83, 83.e1-2. 10.1016\/j.jaad.2009.10.051","journal-title":"J Am Acad Dermatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/DSS.0000000000000974","article-title":"Reliability, validity, and sensitivity to change overtime of the modified melasma area and severity index score","volume":"43","author":"Abou-Taleb DA","year":"2017","unstructured":"Abou-Taleb DA, Ibrahim AK, Youssef EM, Moubasher AE. Reliability, validity, and sensitivity to change overtime of the modified melasma area and severity index score. Dermatol Surg. 2017, 43:210-7. 10.1097\/DSS.0000000000000974","journal-title":"Dermatol Surg"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2003.05419.x","article-title":"Development and validation of a health-related quality of life instrument for women with melasma","volume":"149","author":"Balkrishnan R","year":"2003","unstructured":"Balkrishnan R, McMichael AJ, Camacho FT, et al.. Development and validation of a health-related quality of life instrument for women with melasma. Br J Dermatol. 2003, 149:572-7. 10.1046\/j.1365-2133.2003.05419.x","journal-title":"Br J Dermatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/pcmr.12404","article-title":"Recent progress in melasma pathogenesis","volume":"28","author":"Lee AY","year":"2015","unstructured":"Lee AY. Recent progress in melasma pathogenesis. Pigment Cell Melanoma Res. 2015, 28:648-60. 10.1111\/pcmr.12404","journal-title":"Pigment Cell Melanoma Res"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/medicina58070936","article-title":"The low-fluence Q-switched Nd:YAG laser treatment for melasma: a systematic review","volume":"58","author":"Lee YS","year":"2022","unstructured":"Lee YS, Lee YJ, Lee JM, Han TY, Lee JH, Choi JE. The low-fluence Q-switched Nd:YAG laser treatment for melasma: a systematic review. Medicina (Kaunas). 2022, 58:936. 10.3390\/medicina58070936","journal-title":"Medicina (Kaunas)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/478322-successful-therapeutic-approach-to-facial-hyperpigmentation-secondary-to-addisons-disease-a-case-report-and-literature-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T15:16:00Z","timestamp":1777389360000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/478322-successful-therapeutic-approach-to-facial-hyperpigmentation-secondary-to-addisons-disease-a-case-report-and-literature-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,28]]},"references-count":8,"URL":"https:\/\/doi.org\/10.7759\/cureus.107884","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4,28]]}}}